Acomplia a Loser for Sanofi-Aventis
Weight-Loss Drug Acomplia Adverse Reactions. Five lives have been claimed and 720 adverse drug reactions have occurred in Britain since the launch of France’s Sanofi-Aventis SA's weight-loss drug, Acomplia, two years ago; this, according to a posting on the United Kingdom’s drug regulator’s Website this week. Acomplia—known … [Read more...] about Acomplia a Loser for Sanofi-Aventis
Association of Bextra Tablets Serious Drug Reactions
Pfizer Canada Inc. Suspend The Sale Of Bextra (valdecoxib). Dear Health Care Professional, On 7 April 2005, Pfizer Canada Inc., following discussions with Health Canada, agreed to voluntarily suspend the sale and marketing of BEXTRA (valdecoxib) tablets in Canada pending the submission of BEXTRA’s benefit/risk … [Read more...] about Association of Bextra Tablets Serious Drug Reactions
